Catalogo dei prodotti della ricerca

Marampon, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.763
EU - Europa 1.040
AS - Asia 373
SA - Sud America 15
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.735
IT - Italia 461
SE - Svezia 253
IN - India 197
CN - Cina 124
FI - Finlandia 77
UA - Ucraina 40
DE - Germania 39
IE - Irlanda 36
FR - Francia 31
SG - Singapore 31
CA - Canada 26
RO - Romania 24
GB - Regno Unito 22
BG - Bulgaria 19
HK - Hong Kong 10
AR - Argentina 9
TR - Turchia 8
CH - Svizzera 7
RU - Federazione Russa 7
ZA - Sudafrica 7
CL - Cile 6
AT - Austria 4
BE - Belgio 4
TG - Togo 4
ES - Italia 3
NL - Olanda 3
AL - Albania 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
MX - Messico 2
RS - Serbia 2
AU - Australia 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LT - Lituania 1
MK - Macedonia 1
SC - Seychelles 1
Totale 6.206
Salva come PNG Salva come JPEG
Città #
Fairfield 894
Ashburn 409
Woodbridge 408
Seattle 324
Cambridge 321
Houston 318
Chandler 277
Wilmington 274
Rome 202
Ann Arbor 157
Princeton 139
Lawrence 105
Dearborn 104
San Paolo di Civitate 104
Plano 86
Fremont 84
Boston 70
Millbury 60
Beijing 54
San Diego 49
New York 37
Dublin 36
Helsinki 35
Norwalk 27
Andover 23
Phoenix 22
Falls Church 20
Sofia 19
Des Moines 13
Toronto 13
Nanjing 11
Ottawa 11
Boardman 10
Milan 10
Hefei 9
Hong Kong 9
Federal 8
Istanbul 8
Kunming 8
San Severo 8
Bremen 7
Muizenberg 7
San Mateo 7
Jacksonville 5
London 5
L’Aquila 5
Menlo Park 5
Nanchang 5
Palermo 5
Pescara 5
Termoli 5
Brussels 4
Laurel 4
Lomé 4
Sacramento 4
Singapore 4
Villa Park 4
Ariccia 3
Fuzhou 3
Jinan 3
La Jolla 3
Lappeenranta 3
Marino 3
Shanghai 3
Shenzhen 3
Turin 3
Washington 3
Zurich 3
Anguillara 2
Belgrade 2
Bern 2
Bologna 2
Bühl 2
Chengdu 2
Chicago 2
Chieti 2
Chongqing 2
Flushing 2
Fort Worth 2
Guangzhou 2
Indiana 2
Prescot 2
Pune 2
San Benedetto Ullano 2
Sheffield 2
Soleto 2
Tirana 2
Torrelodones 2
Trento 2
Trumbull 2
Vienna 2
West Jordan 2
Xian 2
Zhengzhou 2
Aktobe 1
Aquila 1
Azcapotzalco 1
Baotou 1
Barcelona 1
Bassano Romano 1
Totale 4.952
Salva come PNG Salva come JPEG
Nome #
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines 113
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 93
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation 93
Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report 90
c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines 88
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 88
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 81
ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program 80
Can radiotherapy be combined with radiofrequency ablation in the management of symptomatic osteolytic skeletal metastasis? 79
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study 78
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 76
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 75
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 75
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population 74
Radiation therapy and serum salivary amylase in head and neck cancer 74
Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells 73
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases 73
MEK/ERK Inhibition by U0126 Radiosensitizes Rhabdomyosarcoma Cells In Vitro and In Vivo 72
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models 72
A Feasibility Study of Percutaneous Radiofrequency Ablation with Radiotherapy in Painful Osteolytic Bone Metastases 71
Defective DNA repair mechanisms in prostate cancer: impact of olaparib 71
5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient Prostate Tumors 71
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 70
The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism 70
5-azacitidine restores and amplifies the response to bicalutamide and radiotherapy on preclinical models of androgen receptor expressing or deficient prostate tumors 69
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 68
Immune check-point in glioblastoma multiforme 68
The small molecule ephrin receptor inhibitor, GLPG1790, Reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models 68
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 68
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer 68
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells 67
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation 66
Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: a pilot study 66
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals 65
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 65
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 64
Cellular and molecular mediators of bone metastatic lesions 64
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 64
Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells 64
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 63
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer 62
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 62
Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: propensity matching analysis in 175 patients 61
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 60
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells 59
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: a retrospective study by propensity analysis 57
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 57
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells 57
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 56
Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models 55
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by down regulating growth and DNA repair signals 55
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models 55
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 55
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 54
The TORC1/TORC2 inhibitor, palomid 529 (P529), reduces tumor growth and sensitizes to chemotherapy and radiotherapy aggressive hormone refractory prostate cancer cells both in vitro and in vivo 54
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR ser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 54
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy 54
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 54
HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers 54
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 54
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 53
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma 53
The role of vaginal brachytherapy in stage I endometrial serous cancer. a systematic review 53
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review 53
Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21 RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-κB 52
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis 52
HORMONAL THERAPY PROMOTES HORMONE-RESISTANT PHENOTYPE BY INCREASING DNMT ACTIVITY AND EXPRESSION IN PROSTATE CANCER MODELS 52
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma 52
Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models 51
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 51
Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models 51
The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugs 51
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples 51
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 51
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 50
Locally advanced rectal cancer. Treatment approach in elderly patients 50
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: cellular, molecular and computational evidence 50
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer 49
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and oncophenotype reversion in rhabdomyosarcoma cells 49
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models 49
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 49
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma 49
Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study 48
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors 48
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors 47
null 47
Bone control of muscle function 47
Antitumorigenic effects of inhibiting ephrin receptor kinase signaling by GLPG1790 against colorectal cancer cell lines In vitro and In vivo 47
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 46
The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical models 45
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models 45
null 44
Phosphodiesterase type-5 inhibitor tadalafil modulates steroid hormones signaling in a prostate cancer cell line 44
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients 40
Neurotoxic and neuroprotective role of exosomes in parkinson’s disease 39
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 38
HISTONE DEACETYLASE INHIBITOR, ROMIDEPSIN (FK228) IMPROVES ANTITUMOR EFFECTS OF DOCETAXEL AND CISPLATIN IN MODELS OF AGGRESSIVE PROSTATE CANCER 37
Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis: a matched explorative active control trial by propensity analysis 36
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 33
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma 32
Totale 5.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019786 0 0 0 0 0 0 0 0 0 143 341 302
2019/20201.839 206 68 31 79 189 257 259 251 200 133 98 68
2020/2021732 81 87 59 29 15 98 9 32 103 127 61 31
2021/20221.265 24 72 118 38 190 41 53 145 79 70 225 210
2022/20231.249 241 293 75 124 102 125 19 70 118 11 44 27
2023/2024516 45 80 33 54 88 91 24 63 14 24 0 0
Totale 6.676